Table 1.

Vaccines features related to sustainability.

Vaccine or Developer representant	Long term storage duration	Short term storage duration	Efficacy	Ref.
HPV	3 years/2–25 °C	1 year/≤ 37 °C	Close to 100%	[27]
Hepatitis B	3 years/2–8 °C	1 month/≤ 37 °C	80–100%	[27]
Ebola rSVΔG-ZEBON-GP	-60 °C	12 hours/2–8 °C	97–100%	[26, 28]
Oxford/Astrazeneca	-4 °C	-	62–90%	[29]
Moderna	6 months/-20 °C	30 days/2–8 °C	94%	[30]
Pfizer/BioNTech	-70 °C	5 days/2–8 °C	95%	[31]
Sputnik V	-4 °C	-	91.4%	[32]